Our Corporate Patron

One Nucleus is delighted that AstraZeneca will continue its long-held relationship as Corporate Patron. For over a decade AstraZeneca has provided significant strategic advice from employees in a variety of departments and roles to help steer our activities. Highlighting AstraZeneca’s commitment to the partnership with One Nucleus, it is our pleasure to have Penny James, Chief Operating Officer, BioPharmaceuticals R&D as a NonExecutive Director. The breadth of this engagement means we have formed a strong and productive relationship with AstraZeneca, based on shared ambitions for the Cambridge and wider UK life sciences community.

Accommodating over 2,200 research scientists nothing illustrates AstraZeneca’s commitment to the region’s life science cluster more clearly that its investment in establishing their new Discovery Centre (DISC). Opened by HRH Prince of Wales in late 2021 the prestigious facility epitomises the future of life science R&D; technologyenabled, collaborative and patient-centric. One Nucleus shares this ambition for the cluster to be the world-leading bioinnovator. One Nucleus strives to enable knowledge sharing on the latest innovations in the scientific, business and investment aspects of the sector. AstraZeneca’s willingness to dedicate resource to us, such as event speakers and updates, significantly enhances our ability to share and debate content across areas including R&D, deal making and sustainability. Their engagement provides insight to the nascent companies, their founding entrepreneurs and investors, on how exceptional scientific innovation can be translated into patient benefit globally.

This fits well with the collective aspirations of our cluster’s ecosystem; to create life changing technologies and products that have a global impact on lives. AstraZeneca’s role as a global leader and regional champion, in terms of science and societal impact includes their local engagement in mentoring-style schemes and strong practices on environment and diversity, exemplifying the aspirations of the cluster and One Nucleus’s desire to promote the region as the best place for life science talent to work, live and collaborate.

Tony Jones, CEO